{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/fa3ecf27-4910-41db-9127-4174e03e78df/62c712d93c109c0012149420?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"PROTACs Roundtable: Bertozzi and Deshaies","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b47d42e8568ca498578e/1657891154065-9d326d56cf578c3b9dce787fd9637864.jpeg?height=200","description":"<p>Senior Editor Markus Elsner has a discussion with Ray Deshaies and Carolyn Bertozzi about PROTACs, small molecules that have the potential to treat previously-undruggable targets in clinical applications.</p>","author_name":"Nature Biotechnology"}